T cell biomarker predicts which CLL patients will respond to CAR T cell therapy – Science Daily
|
T cell biomarker predicts which CLL patients will respond to CAR T cell therapy
Science Daily Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don't respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed patients' immune systems are … |
